Loading the company…
Loading the company…
Families: Tumor & fibroid embolization, Aneurysm & intracranial embolization, BPH procedures.
All companies · Product and company coverage
In the last ten years FDA made 8 decisions for Biosphere Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2019 (3). The latest was on 2025-05-16.
| Family | Decisions on record |
|---|---|
| Tumor & fibroid embolization | 10 |
| Aneurysm & intracranial embolization | 3 |
| BPH procedures | 1 |
| EmboCube Embolization Gelatin |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Biosphere Medical.